The president recently touted the idea, which came to a 30-year-old investor in a dream and caught the attention of Elon Musk ...

President Donald Trump recently touted the of "DOGE dividends," which came to a 30-year-old investor in a dream and caught ...

When the 340B program was first launched, pharmaceutical manufacturers were to provide medications at a discounted price for ...

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Rightway, the only PBM purpose-built for transparency and fiduciary alignment, today released its 2024 PBM Annual Report, showcasing another year of ...

A state Senate committee advanced a measure that would allow doctors to prescribe appropriate meds to patients with mental ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." ...

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...